Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
Henry Coop recently graduated from the University of Oxford with an MPhys degree specialising in quantum physics and now works as a trainee patent attorney at Dehns. In this article, he reflects on specialising in quantum information processing, condensed matter physics and quantum computing at Oxford, and how that academic background now supports his work in intellectual property and emerging technologies.
Hot on the heels of Luke Littler’s much-discussed application to register his facial image as a trade mark, Taylor Swift’s company TAS Rights Management has filed three new trade mark applications with the United States Patent and Trademark Office (“USPTO”) — two audio clips of her voice and one photograph of her on stage.
The recent application by Luke Littler to protect an image of his face as a trade mark in the UK has understandably attracted a lot of media attention. Whilst filing trade mark applications for portrait images is still something of a novelty, the application is likely to represent more than a creative attempt at brand protection, but rather a strategic response to the rapidly evolving threat posed by AI.
Cosmetic giant, Estée Lauder has launched legal proceedings in the High Court against perfumer Jo Malone, her fragrance company Jo Loves, and high street retailer, Zara, for trade mark infringement, passing off, and breach of contract.
Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
Subscribe here for updates on IP news, events and webinars.
|